NYPROVIO Trademark

Trademark Overview


On Wednesday, September 22, 2021, a trademark application was filed for NYPROVIO with the United States Patent and Trademark Office. The USPTO has given the NYPROVIO trademark a serial number of 97039737. The federal status of this trademark filing is ABANDONED - EXPRESS AFTER PUB as of Wednesday, August 10, 2022. This trademark is owned by Glaxo Group Limited. The NYPROVIO trademark is filed in the Pharmaceutical Products category with the following description:

(Based on 44(d) Priority Application) Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders(Based on 44(e)) Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointes...
nyprovio

General Information


Serial Number97039737
Word MarkNYPROVIO
Filing DateWednesday, September 22, 2021
Status605 - ABANDONED - EXPRESS AFTER PUB
Status DateWednesday, August 10, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 26, 2022

Trademark Statements


Goods and Services(Based on 44(d) Priority Application) Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders(Based on 44(e)) Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code8 - Abandoned
Class Status DateWednesday, August 10, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Trademark Events


Event DateEvent Description
Wednesday, August 10, 2022ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION
Wednesday, August 10, 2022ABANDONMENT - AFTER PUBLICATION
Tuesday, July 26, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 26, 2022PUBLISHED FOR OPPOSITION
Tuesday, July 12, 2022TEAS EXPRESS ABANDONMENT RECEIVED
Wednesday, July 6, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, June 23, 2022ELECTRONIC RECORD REVIEW COMPLETE
Friday, June 17, 2022ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Tuesday, June 14, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, June 14, 2022ASSIGNED TO EXAMINER
Monday, October 25, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, September 25, 2021NEW APPLICATION ENTERED IN TRAM